TD Private Client Wealth
WVE icon

TD Private Client Wealth’s Wave Life Sciences WVE Stock Holding History

TD Private Client Wealth’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$540 Buy
+146
New +$768 ﹤0.01% 1640
2025
Q2 		– Sell
-126
Closed -$1.02K – 1527
2025
Q1 		$1.02K Buy
+126
New +$1.38K ﹤0.01% 1291

Other funds holding WVE

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
James J. Burns & Company
James J. Burns & Company Melville, New York $937M AUM 13.35% 1-Year Est. Return
Carolina Wealth Management
Carolina Wealth Management Greenville, North Carolina $233M AUM
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Matisse Capital
Matisse Capital Portland, Oregon $256M AUM 15.28% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

TD Private Client Wealth's WVE Position: Q3 2026 in Review

TD Private Client Wealth opened a new position in Wave Life Sciences (WVE) in Q3 2026: 146 shares worth $540. The stake represents ﹤0.01% of the portfolio and ranks #1640 among its holdings. This is a return to the name: TD Private Client Wealth previously reported a position in WVE as recently as Q1 2025.

TD Private Client Wealth first reported a position in WVE in Q1 2025 and has held it in 2 quarters since. The position peaked at $1.02K in Q1 2025. 34 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

  • TD Private Client Wealth held 146 shares of Wave Life Sciences worth $540 as of Q3 2026.
  • Wave Life Sciences was a new TD Private Client Wealth position in Q3 2026.
  • Wave Life Sciences made up ﹤0.01% of TD Private Client Wealth's portfolio in Q3 2026, its #1640 holding.
  • TD Private Client Wealth first reported a position in Wave Life Sciences in Q1 2025 and has held it in 2 quarters since.
  • TD Private Client Wealth's Wave Life Sciences position peaked at $1.02K in Q1 2025.
  • 34 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on TD Private Client Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.